Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 9:1:119-29.
doi: 10.2147/ijwh.s4517.

Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine

Maria Lina Diaz  1
Affiliations

Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine

Maria Lina Diaz. Int J Womens Health. .

Abstract

The relationship between the human papillomavirus (HPV) and malignancies of the uterine cervix, vagina, and vulva has been established. The development of a quadrivalent HPV recombinant prophylactic vaccine represents the first time in history that primary prevention of these cancers is offered to girls and women. The prevalence of oncogenic HPV subtypes in cervical cancers has been the most studied, but prevalence has also been established for vaginal and vulvar cancers. Clinical trials demonstrate impressive efficacy in disease prevention as well as excellent safety and tolerability. The role the quadrivalent HPV recombinant vaccine promises to have in the reduction of gynecologic malignancies will depend on various factors, including acceptance and accessibility of the vaccine, duration of immunity, and cross-protection against other oncogenic HPV subtypes. The HPV vaccine's role in disease reduction will probably be viewed in the context of a strategy that involves continued secondary screening and lifestyle modification to reduce modifiable risk factors, along with widespread vaccination.

Keywords: cervical cancer; human papillomavirus; quadrivalent vaccine; vaginal cancer; vulvar cancer.

PubMed Disclaimer

References

    1. Chang MH. Cancer prevention by vaccination against Hepatitis B. Recent results. Cancer Res. 2009;181:85–95. - PubMed
    1. De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of human papillomaviruses. Virology. 2004;324(1):17–27. - PubMed
    1. Chan SY, Delius H, Halpern AL, Bernard HU. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny and taxonomy. J Virol. 1995;69(5):3074–3083. - PMC - PubMed
    1. IARC. Vol. 64. Lyon (France): International Agency for Research on Cancer; 1995. IARC monographs on the evaluation of carcinogenic risks to humans Human papillomaviruses.
    1. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic disease. Vaccine. 2006;24(Suppl 3):S26–S34. - PubMed

LinkOut - more resources